ALKERMES PLC ORD (ALKS)

Overview Price 18.47 Price Change Today 0.00 (0.00%) P&P rating Zacks Rank 3 - HOLD Open Price $0.00 Previous Close $18.47 Daily Range $0.00 - $0.00 52-Week Range $11.86 - $0.00 Volume 0 Alkermes, Inc. is a biotechnology company that develops innovative medicines designed to yield better therapeutic outcomes and improve the lives of patients with serious disease. Alkermes currently has two commercial products: RISPERDAL CONSTA, the first and only long-acting atypical antipsychotic medication approved for use in schizophrenia, and marketed worldwide by Janssen-Cilag, a wholly owned division of Johnson & Johnson; and VIVITROL the first and only once-monthly injectable medication approved for the treatment of alcohol dependence and marketed in the U.S. primarily by Cephalon, Inc. Alkermes' pipeline includes extended-release injectable, pulmonary, and oral products for the treatment of prevalent, chronic diseases such as central nervous system disorders, addiction and diabetes. Other Resources for ALKS Detailed Quote Earnings Estimates Company Report Interactive Chart Commentary Zacks Blog: Novo Nordisk Posts Solid 4Q February 6, 2012 Zacks Blog: The Zacks Analyst Blog Highlights: Alkermes plc, Elan, Johnson & Johnson, Amylin Pharmaceuticals and Eli Lilly & Company February 6, 2012 Zacks Blog: Revenues Skyrocket at Merged Alkermes February 3, 2012 Zacks Blog: New Study for Alkermes' Vivitrol February 1, 2012 Zacks Blog: Zyprexa Pulls Down Lilly's 4Q Sales January 31, 2012 Alkermes, Inc. is a biotechnology company that develops innovative medicines designed to yield better therapeutic outcomes and improve the lives of patients with serious disease. Alkermes currently has two commercial products: RISPERDAL CONSTA, the first and only long-acting atypical antipsychotic medication approved for use in schizophrenia, and marketed worldwide by Janssen-Cilag, a wholly owned division of Johnson & Johnson; and VIVITROL the first and only once-monthly injectable medication approved for the treatment of alcohol dependence and marketed in the U.S. primarily by Cephalon, Inc. Alkermes' pipeline includes extended-release injectable, pulmonary, and oral products for the treatment of prevalent, chronic diseases such as central nervous system disorders, addiction and diabetes.   Brokerage Analyst Recommendations 10 Brokerage Firms Covering ALKS   Strong Buy 9 Buy 0 Hold 1 Sell 0 Strong Sell 0 Average Broker Recommendation (ABR): 1.2   ALKS Ratings: BUY  SELL  HOLD ALKS Consensus Forecasts

Rate this Stock! You haven't rated this stock yet! Ticker Call Buy Sell Analysis Time Frame Week or Less Week to a Month One to Three Months Three to Six Months Six Months to a Year One to Three Years Three Plus Years What The Community Thinks Total Players 39 Buy 1 Sell   Top Buy Analysis BUY: ALKS Company: ALKERMES INC. Points: 10.18 Start Price: $14.25 Start Date: 08/09/2010 5:11 PM farfetched1 P&P Score: 98.69 Recs: This stock is sitting at the entry point for risk and reward for the diabetic market potential. It;s cheap from the current value if looking at forward looking Earnings... Comments: 0 | Comment More Recent Analysis Top Sell Analysis SELL: ALKS Company: ALKERMES INC. Points: 6.45 Start Price: $21.64 Start Date: 01/01/2008 12:00 AM nateric P&P Score: 22.54 Recs: Comments: 0 | Comment More Recent Analysis

Blog Posts

User	User Score	Date	Title	Comments	Last Comment
Vet67to82	95.96	04/08/11	Seagate Tech (STX) FairValue	2	01/21/12
Vet67to82	95.96	02/22/11	To buy or not to buy? That is the question.	1	02/22/11
Vet67to82	95.96	01/28/11	Friday January 28, 2011 - When Opportunity Knocks	0
Vet67to82	95.96	11/11/10	Thursday, 11/11/2010 OurCall for the Close	9	11/11/10
Vet67to82	95.96	11/10/10	Wednesday, 11/10/2010 OurCall for the Close	15	11/10/10
Vet67to82	95.96	11/09/10	Tuesday, 11/9/2010 OurCall for the Close	8	11/09/10
Vet67to82	95.96	11/07/10	Monday, 11/8/2010 OurCall for the Close	18	11/09/10
Vet67to82	95.96	11/05/10	Friday, 11/5/2010 OurCall for the Close	8	11/05/10
Vet67to82	95.96	11/04/10	Thursday, 11/4/2010 OurCall for the Close	9	11/04/10
Vet67to82	95.96	11/03/10	Be Thee Bull or Bear	3	11/04/10

Pages: [ 1 ]  2   3   4   5   ...  11  >>

Commentary

BUY: ALKERMES INC. (ALKS) Start Price: $14.25 Points: +10.18 Created: 08/09/2010 This stock is sitting at the entry point for risk and reward for the diabetic market potential. It;s cheap from the current value if looking at forward looking Earnings... Comments: 0 | Comment farfetched1 Recs:

BUY: ALKERMES INC. (ALKS) Start Price: $15.35 Points: +13.25 Created: 07/25/2008 Comments: 0 | Comment Future1investor Recs:

BUY: ALKERMES INC. (ALKS) Start Price: $12.59 Points: +47.80 Created: 06/16/2008 Comments: 0 | Comment LeveneOMurray Recs:

BUY: ALKERMES INC. (ALKS) Start Price: $24.35 Points: -15.98 Created: 01/01/2008 Comments: 0 | Comment beach lady Recs:

SELL: ALKERMES INC. (ALKS) Start Price: $21.64 Points: +6.45 Created: 01/01/2008 Comments: 0 | Comment nateric Recs:

BUY: ALKERMES INC. (ALKS) Start Price: $21.72 Points: -6.77 Created: 01/01/2008 Comments: 0 | Comment JakEck Recs:

BUY: ALKERMES INC. (ALKS) Start Price: $21.94 Points: -7.62 Created: 01/01/2008 Comments: 0 | Comment visionary Recs:

BUY: ALKERMES INC. (ALKS) Start Price: $16.77 Points: +18.42 Created: 01/01/2008 Comments: 0 | Comment mikeherald Recs:

BUY: ALKERMES INC. (ALKS) Start Price: $24.80 Points: -17.36 Created: 01/01/2008 Comments: 0 | Comment roadrunner Recs:

BUY: ALKERMES INC. (ALKS) Start Price: $24.72 Points: -17.12 Created: 01/01/2008 Comments: 0 | Comment RightPassive Recs:

Pages: [ 1 ]  2   3   4  >>

Picks

Username	P&P Score	Call	Time Frame	Start Date	Start Price	Today (change)	Stock Gain	S&P Gain	Points	Analysis
farfetched1	98.69	BUY	Week to a Month	08/09/2010	$14.25	$18.53 (-1.49%)	+30.04%	+19.85%	+10.18	view close
Future1investor	27.37	BUY	Week to a Month	07/25/2008	$15.35	$18.53 (-1.49%)	+20.72%	+7.47%	+13.25
LeveneOMurray	0.45	BUY	Week to a Month	06/16/2008	$12.59	$18.53 (-1.49%)	+47.18%	-0.62%	+47.80
beach lady	57.64	BUY	Six Months to a Year	01/01/2008	$24.35	$18.53 (-1.49%)	-23.90%	-7.92%	-15.98
nateric	22.54	SELL	Six Months to a Year	01/01/2008	$21.64	$18.53 (-1.49%)	-14.37%	-7.92%	+6.45
JakEck	28.55	BUY	Six Months to a Year	01/01/2008	$21.72	$18.53 (-1.49%)	-14.69%	-7.92%	-6.77
visionary	54.84	BUY	Six Months to a Year	01/01/2008	$21.94	$18.53 (-1.49%)	-15.54%	-7.92%	-7.62
mikeherald	83.06	BUY	Six Months to a Year	01/01/2008	$16.77	$18.53 (-1.49%)	+10.49%	-7.92%	+18.42
roadrunner	40.97	BUY	Six Months to a Year	01/01/2008	$24.80	$18.53 (-1.49%)	-25.28%	-7.92%	-17.36
RightPassive	23.17	BUY	Six Months to a Year	01/01/2008	$24.72	$18.53 (-1.49%)	-25.04%	-7.92%	-17.12

Pages: [ 1 ]  2   3   4  >>